Description: Elixxer Ltd. operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland. It invests in cultivation, production, and/or sale of medical cannabis and cannabis-derived products in the pharmaceutical sector. The company was formerly known as LGC Capital Ltd. and changed its name to Elixxer Ltd. in August 2019. Elixxer Ltd. was incorporated in 2004 and is based in Montreal, Canada.
Home Page: www.elixxer.com
1100 Boulevard Rene- Levesque Ouest
Montreal,
QC
H5B 4N4
Canada
Phone:
514 788 1499
Officers
| Name | Title |
|---|---|
| Mr. Ferras Zalt | Chairman & Interim CEO |
| Ms. Kym No C.M.A., CPA | Corporate Controller & Interim CFO |
| Mr. Guy Charette L.L.B., LL.B. | Legal Council |
| Ms. Jeanne van Wyk | Vice President of Communications |
| Mr. Daniel Lubienietzky | VP of Corporate Development |
| Mr. Richard Widmann | EVP of Commercial |
| Mr. Michael Kozub | Corporate Secretary |
Exchange: V
Country: CA : Canada
Currency: Canadian Dollar (C$)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 2.669 |
| Price-to-Sales TTM: | 767773.8 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |